ARCT stock forecast
Our latest prediction for Arcturus Therapeutics Holdings, Inc.'s stock price was made on the June 10, 2020 when the stock price was at 31.55$.
In the short term (2weeks), ARCT's stock price should outperform the market by 2.25%. During that period the price should oscillate between -10.82% and +13.29%.
In the medium term (3months), ARCT's stock price should underperform the market by -5.53%. During that period the price should oscillate between -37.15% and +29.28%.Get email alerts
Create a solid portfolio with ARCT
About Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.
At the moment the company generates 11M USD in revenues.
On its last earning announcement, the company reported a loss of -2.61$ per share.
The book value per share is 0.48$
Three months stock forecastJune 10, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|